New drug shows promise for brain bleed patients

NCT ID NCT05970224

Ongoing Disease control Sponsor: Bioxodes S.A. Source: ClinicalTrials.gov ↗

First seen Apr 08, 2026 · Last updated May 21, 2026 · Updated 7 times

Summary

This study tests a new drug called Ir-CPI in people who have had a brain bleed. The goal is to see if it is safe and can help reduce further brain damage when added to standard care. About 23 adults with a first-time brain bleed will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

AZ Damiaan

Ostend, West Flanders, 8400, Belgium
AZ Groeninge

Kortrijk, West Flanders, 8500, Belgium
AZ Sint-Jan

Bruges, West Flanders, 8000, Belgium
CHU Ambroise Paré

Mons, Hainaut, 7000, Belgium
Clinique CHC MontLégia

Liège, Belgium
HUB Erasme

Brussels, Brussels Capital, 1070, Belgium
UCL St Luc

Brussels, Brussels Capital, Belgium
UZ Brussel

Brussels, Brussels Capital, Belgium
UZ Gent

Ghent, East Flanders, 9000, Belgium
UZ Leuven

Leuven, Flemish Brabant, Belgium

Conditions

Explore the condition pages connected to this study.

INTRACEREBRAL HEMORRHAGE